Clinical Observation on Recombinant Human Endostatin Combined with Chemotherapy for Advanced Gastrointestinal Cancer |
Gao, Shao-Rong
(The Third Department of Chemotherapy, Weihai Municipal Hospital)
Li, Lu-Ming (Internal Medicine, Weihai Municipal Hospital) Xia, Hai-Ping (The First Department of Surgery, 404 Hospital of the Chinese People's Liberation Army) Wang, Guang-Ming (Pharmacy Department, Weihai Municipal Hospital) Xu, Hong-Yan (The Third Department of Chemotherapy, Weihai Municipal Hospital) Wang, Ai-Rong (The Third Department of Chemotherapy, Weihai Municipal Hospital) |
1 | Chen G, Shen ZL, Wang L, et al (2013). Hsa-miR-181a-5p expression and effects on cell proliferation in gastric cancer. Asian Pac J Cancer Prev, 14, 3871-5. DOI ScienceOn |
2 | Chen YX, Qin SK, Liu XF, et al (2009). Clinical study of rh-endostatin combined with chemotherapy for advanced gastric cancer. Chin Clin Oncol, 14, 327-31. |
3 | FolkmanJ, MerlerE, AbernathyC, etal. Isolated of a tumor factor responsible for anfiogesis. J Exp Med, 1971, 133, 275-88. DOI |
4 | Ge W, Cao DD, Wang HM, et al (2011). Endostar Combined with Chemotherapy versus Chemotherapy alone for Advanced NSCLCs: A Meta-analysis. Asian Pac J Cancer Prev, 12, 2901-7. |
5 | Kirschm, Schackert G, Black PM (2004). Metastasis and angiogenesis. Cancer Treat Res, 117, 285. DOI |
6 | Liu J, Huang XE, Feng JF (2014). Further study on pemetrexed based chemotherapy in treating patients with advanced gastric cancer (AGC). Asian Pac J Cancer Prev, 15, 6587-90. DOI |
7 | O'Reilly MS, Boehm T, Shing Y (1997). Endostain: an endogenous inhibitor of angiofenesis and tumor growth. Cell, 88, 277-85. DOI |
8 | Sun Y, Shi YK (2007). Manual of Clinical Oncology. People's Medical Publishing House, 492-6, 817-9. |
9 | Shao Mingwen, Qiu Jinrong, Wu Hao, et al (2014). Mechanism of Shenyi Capsule Concomitant with Endostar and Chemotherapy on the Growth and Apoptosis of MCF-7 Breast Cancer Cells. J Int Transl Med, 2, 299-302. |
10 | Wang JW, Sun Y, Liu YY, et al (2005). Results of randomized, multicenter, double blind phase III trial of rh-endostatin (YH16) in treatment of advanced non-small cell lung cancer patients. Chin J Lung Cancer, 8, 283-90. |
11 | Li Y, Huang XE, Yan PW, et al (2010). Efficacy and Safety of Endostar Combined with Chemotherapy in Patients with Advanced Solid Tumors. Asian Pac J Cancer Prev, 11, 1119-23. |
12 | Wei GL, Huang XE, Huo JG, et al (2013). Phase II study on pemetrexed-based chemotherapy in treating patients with metastatic gastric cancer not responding to prior palliative chemotherapy. Asian Pac J Cancer Prev, 14, 2703-6. DOI ScienceOn |
13 | Xu X, Wang L, Xu HQ, et al (2013). Clinical comparison between paclitaxel liposome (Lipusu) and paclitaxel for treatment of patients with metastatic gastric cancer. Asian Pac J Cancer Prev, 4, 2591-4. |